[1]
T. Agarwal, N. Annamalai, H. P. Ronanki, S. Butty, T. K. Maiti, and H. B. Arsad, “MUTANT P21 PEPTIDES COULD ACT AS AN IMPROVED CYCLIN A INHIBITORS FOR CANCER THERAPY: AN IN SILICO VALIDATION”, Int J Pharm Pharm Sci, vol. 11, no. 2, pp. 59-64, Dec. 2018.